These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 36818141)

  • 1. Evaluation and Management of Patients With Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement.
    Lee KS; Noh J; Park SM; Choi KM; Kang SM; Won KC; Cho HJ; Moon MK;
    Int J Heart Fail; 2023 Jan; 5(1):1-20. PubMed ID: 36818141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and Management of Patients with Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement.
    Lee KS; Noh J; Park SM; Choi KM; Kang SM; Won KC; Cho HJ; Moon MK
    Diabetes Metab J; 2023 Jan; 47(1):10-26. PubMed ID: 36727161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Management in Korean People With Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement.
    Yang YS; Kim HL; Kim SH; Moon MK;
    J Lipid Atheroscler; 2023 Jan; 12(1):12-22. PubMed ID: 36761063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Understanding for Application in Korean Patients with Type 2 Diabetes Mellitus of the Consensus Statement on Carbohydrate-Restricted Diets by Korean Diabetes Association, Korean Society for the Study of Obesity, and Korean Society of Hypertension.
    Choi JH; Kang JH; Chon S
    Diabetes Metab J; 2022 May; 46(3):377-390. PubMed ID: 35656561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update.
    Dunlay SM; Givertz MM; Aguilar D; Allen LA; Chan M; Desai AS; Deswal A; Dickson VV; Kosiborod MN; Lekavich CL; McCoy RG; Mentz RJ; Piña IL;
    Circulation; 2019 Aug; 140(7):e294-e324. PubMed ID: 31167558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expert consensus on the diagnosis and treatment of obstructive sleep apnea in women].
    Chinese Thoracic Society
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jun; 47(6):509-528. PubMed ID: 38858201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America.
    Dunlay SM; Givertz MM; Aguilar D; Allen LA; Chan M; Desai AS; Deswal A; Dickson VV; Kosiborod MN; Lekavich CL; McCoy RG; Mentz RJ; PiÑa IL; ; ;
    J Card Fail; 2019 Aug; 25(8):584-619. PubMed ID: 31174952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid Management in Korean People with Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement.
    Yang YS; Kim HL; Kim SH; Moon MK
    Diabetes Metab J; 2023 Jan; 47(1):1-9. PubMed ID: 36727160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and management.
    Ceriello A; Catrinoiu D; Chandramouli C; Cosentino F; Dombrowsky AC; Itzhak B; Lalic NM; Prattichizzo F; Schnell O; Seferović PM; Valensi P; Standl E;
    Cardiovasc Diabetol; 2021 Nov; 20(1):218. PubMed ID: 34740359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart Failure in Type 2 Diabetes Mellitus.
    Kenny HC; Abel ED
    Circ Res; 2019 Jan; 124(1):121-141. PubMed ID: 30605420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of metabolic dysfunction-associated fatty liver disease and diabetic kidney disease on the risk of hospitalization of heart failure in type 2 diabetes: a retrospective cohort study.
    Lee SE; Yoo J; Kim BS; Choi HS; Han K; Kim KA
    Diabetol Metab Syndr; 2023 Mar; 15(1):32. PubMed ID: 36855144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases.
    Chiang CE; Lin SY; Lin TH; Wang TD; Yeh HI; Chen JF; Tsai CT; Hung YJ; Li YH; Liu PY; Chang KC; Wang KL; Chao TH; Shyu KG; Yang WS; Ueng KC; Chu PH; Yin WH; Wu YW; Cheng HM; Shin SJ; Huang CN; Chuang LM; Lin SJ; Yeh SJ; Sheu WH; Lin JL
    J Chin Med Assoc; 2018 Mar; 81(3):189-222. PubMed ID: 29453020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetes mellitus and chronic heart failure].
    Spinar J; Vítovec J
    Vnitr Lek; 2003 Dec; 49(12):927-34. PubMed ID: 15040157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium-Glucose Cotransporter-2 Inhibitor for Renal Function Preservation in Patients with Type 2 Diabetes Mellitus: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement.
    Oh TJ; Moon JY; Hur KY; Ko SH; Kim HJ; Kim T; Lee DW; Moon MK; ;
    Diabetes Metab J; 2020 Aug; 44(4):489-497. PubMed ID: 32856800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Carbohydrate-Restricted Diets and Intermittent Fasting on Obesity, Type 2 Diabetes Mellitus, and Hypertension Management: Consensus Statement of the Korean Society for the Study of Obesity, Korean Diabetes Association, and Korean Society of Hypertension.
    Choi JH; Cho YJ; Kim HJ; Ko SH; Chon S; Kang JH; Kim KK; Kim EM; Kim HJ; Song KH; Nam GE; Kim KI; ; ; ;
    J Obes Metab Syndr; 2022 Jun; 31(2):100-122. PubMed ID: 35670159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus statement on the current pharmacological prevention and management of heart failure.
    Sindone AP; De Pasquale C; Amerena J; Burdeniuk C; Chan A; Coats A; Hare DL; Macdonald P; Sverdlov A; Atherton JJ
    Med J Aust; 2022 Aug; 217(4):212-217. PubMed ID: 35908234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rethinking the Impact and Management of Diabetes in Heart Failure Patients.
    Schütt K
    Curr Heart Fail Rep; 2024 Feb; 21(1):53-60. PubMed ID: 38047986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Carbohydrate-Restricted Diets and Intermittent Fasting on Obesity, Type 2 Diabetes Mellitus, and Hypertension Management: Consensus Statement of the Korean Society for the Study of Obesity, Korean Diabetes Association, and Korean Society of Hypertension.
    Choi JH; Cho YJ; Kim HJ; Ko SH; Chon S; Kang JH; Kim KK; Kim EM; Kim HJ; Song KH; Nam GE; Kim KI; ; ; ; ;
    Diabetes Metab J; 2022 May; 46(3):355-376. PubMed ID: 35656560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2020 Consensus of Taiwan Society of Cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases.
    Chiang CE; Ueng KC; Chao TH; Lin TH; Wu YJ; Wang KL; Sung SH; Yeh HI; Li YH; Liu PY; Chang KC; Shyu KG; Huang JL; Tsai CD; Hung HF; Liu ME; Chao TF; Cheng SM; Cheng HM; Chu PH; Yin WH; Wu YW; Chen WJ; Lai WT; Lin SJ; Yeh SJ; Hwang JJ
    J Chin Med Assoc; 2020 Jul; 83(7):587-621. PubMed ID: 32628427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium-glucose cotransporter-2 inhibitor for renal function preservation in patients with type 2 diabetes mellitus: A Korean Diabetes Association and Korean Society of Nephrology consensus statement.
    Oh TJ; Moon JY; Hur KY; Ko SH; Kim HJ; Kim T; Lee DW; Moon MK;
    Kidney Res Clin Pract; 2020 Sep; 39(3):269-283. PubMed ID: 32938820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.